Surface Oncology, Inc. (SURF): Price and Financial Metrics
SURF Price/Volume Stats
| Current price | $1.07 | 52-week high | $1.43 |
| Prev. close | $1.08 | 52-week low | $0.56 |
| Day low | $1.01 | Volume | 1,510,100 |
| Day high | $1.09 | Avg. volume | 430,375 |
| 50-day MA | $0.96 | Dividend yield | N/A |
| 200-day MA | $0.82 | Market Cap | 65.08M |
SURF Stock Price Chart Interactive Chart >
Surface Oncology, Inc. (SURF) Company Bio
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company’s lead product candidate is the SRF231 that is in Phase I clinical trial targeting protein called cluster of differentiation (CD) 47. It is also developing SRF373 inhibiting CD73; SRF617 inhibiting CD39; and SRF388, an antibody targeting interleukin 27. The company has a collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies. Surface Oncology, Inc. was founded in 2014 and is based in Cambridge, Massachusetts.
SURF Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -79.58% |
| 5-year | -46.50% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -82.85% |
| 2021 | -48.27% |
| 2020 | 391.49% |
| 2019 | -55.66% |
Continue Researching SURF
Want to do more research on Surface Oncology Inc's stock and its price? Try the links below:Surface Oncology Inc (SURF) Stock Price | Nasdaq
Surface Oncology Inc (SURF) Stock Quote, History and News - Yahoo Finance
Surface Oncology Inc (SURF) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...